Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Regulatory News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.20 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.30
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dispatch of Annual Report and Shareholder Circular

9 Nov 2017 07:00

RNS Number : 7186V
Physiomics PLC
09 November 2017
 

 

9th November 2017

Physiomics plc

("Physiomics") or ("the Company")

 

Dispatch of Annual Report and Shareholder Circular

 

 

Dispatch of Documentation

Physiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has published and posted to shareholders

- its Annual Report for the financial year ended 30th June 2017 and

- a circular in relation to its forthcoming Annual General Meeting

 

As already announced on the 16th October 2017, the Company's Annual General Meeting will be held at 10:00 a.m. on 13th December 2017 at the Company's registered office, The Magdalen Centre, Oxford Science Park, Robert Robinson Avenue, Oxford, OX4 4GA.

 

 

Resolutions To Be Proposed At The Annual General Meeting

 

Ordinary Resolutions:

1. To receive and adopt the financial statements and the report of the directors and auditors of the Company for the period ended 30 June 2017.

2. To re-appoint Dr Jim Millen as a Director of the Company

3. To confirm the appointment of Shipleys LLP as auditors of the Company to hold office until the conclusion of the next Annual General Meeting at which annual accounts of the Company are laid and to authorise the Directors to fix their remuneration

4. To authorise the directors to allot shares pursuant to section 551 of the Companies Act 2006.

 

Special Resolution

5. To disapply section 561 of the Companies Act 2006 in relation to the allotment in resolution (4) above.

 

 

EXPECTED TIMETABLE OF EVENTS

Latest time for receipt of Forms of Proxy:

 10 a.m. on 11th December 2017

Annual General Meeting:

10 a.m. on 13th December 2017

 

ADDITIONAL STATISTICS

Number of Existing Ordinary Shares of 0.4p in issue at the date of this document

 

57,016,579

 

 

A copy of the Circular containing further details of the resolutions as well as a copy of the Company's Annual Report will be made available on the Company's website.

 

 

 

 

Enquiries:

 

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

 

WH Ireland Limited (nomad)

Katy Mitchell

+44 (0) 161 832 2174

 

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFLALILRIID
Date   Source Headline
7th Jul 20227:00 amRNSTrading update
4th May 20227:00 amRNSPhysiomics expands technical team
29th Apr 202210:00 amRNSIssue of Options
8th Apr 20227:00 amRNSContract award
29th Mar 20227:00 amRNSAppointment of Independent Non-Executive Director
7th Mar 20227:00 amRNSInterim Results
2nd Mar 20227:00 amRNSContract award
2nd Mar 20227:00 amRNSNotice of Interim Results & Investor Presentation
23rd Feb 20227:00 amRNSBoard Changes
21st Feb 202210:00 amRNSDoseMeRx Update
19th Jan 202212:30 pmRNSIssue of Equity
22nd Dec 202112:00 pmRNSContract award
13th Dec 20217:00 amRNSMerck Contracts
23rd Nov 20213:30 pmRNSResult of AGM
12th Nov 202112:00 pmRNSConference presentation
12th Nov 202112:00 pmRNSConference presentation
27th Oct 20211:00 pmRNSPosting of Annual Report and AGM Notice
22nd Oct 20217:00 amRNSContract awards
30th Sep 20213:00 pmRNSResults Presentation and DoseMeRx Update
30th Sep 20217:00 amRNSFinal Results
16th Sep 20212:45 pmRNSPARNTER study recruits first patient
15th Sep 20217:00 amRNSNotice of Results and Investor Presentation
31st Aug 20217:00 amRNSPhysiomics hires Head of Business Development
19th Jul 20217:00 amRNSPhysiomics expands technical team
29th Jun 20219:16 amRNSDirector Dealing
21st May 20214:40 pmRNSDirector Dealing
21st May 20217:00 amRNSContract awards
14th May 20217:00 amRNSContract award
11th May 20217:00 amRNSContract award
10th May 20217:00 amRNSTrading update
9th Apr 20212:00 pmRNSConference presentation
22nd Mar 20217:00 amRNSDirector/PDMR Shareholding
12th Mar 20217:00 amRNSPresentation and Q&A on Company's Interim Results
4th Mar 20217:00 amRNSInterim Results Presentation
2nd Mar 202110:12 amRNSIssue of Options
1st Mar 20217:00 amRNSInterim Results
15th Feb 20217:00 amRNSValiRx Agreement
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20202:00 pmRNSPartnership with TRHC's DoseMeRx®
17th Dec 20207:00 amRNSMerck Contracts
14th Dec 20207:00 amRNSApproval of NIHR-funded PARTNER study
17th Nov 202012:59 pmRNSResult of AGM
22nd Oct 20208:30 amRNSPosting of Annual Report and AGM Notice
22nd Oct 20207:00 amRNSPosting of Annual Report and AGM Notice
16th Oct 20207:00 amRNSContract awards
6th Oct 20209:00 amRNSPresentation and Q&A on Company’s Final Results
30th Sep 20207:00 amRNSFinal Results and Notice of AGM
25th Sep 20207:00 amRNSFull year results release date and shareholder Q&A
11th Sep 20207:00 amRNSHolding(s) in Company
12th Aug 20207:00 amRNSDirector Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.